ESMO Congress-Madrid Spain October 20-24, 2023      FPN: 439P Testing HR+ / HER2- patients with advanced or metastatic breast cancer for identification of tissue mutations in the PIK3CA gene. Results of a national program by the Hellenic Society of Medical Oncology (HeSMO) &nbs...